Back

The Role of Neuropeptide Y in Human Cardiac Hypertrophy after Myocardial Infarction

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Cardiac hypertrophy and pressure overload Cardiac Hypertrophy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Lilli Ganzer

(United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Endothelial redox signalling safeguards metabolic and transcriptional integrity and blocks middle-age cardiac hypertrophy
Ms M. Drekolia (Mannheim, DE)
Abstract Slides Video
Presentation thumbnail
Ketone bodies independently of metabolic pathway attenuate cardiac hypertrophy through β-hydroxybutyrylation
Doctor J. Du (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Sestrin2 protects against pressure overload–induced pathological cardiac hypertrophy via ULK1
Mr T. Liu (CN)
Abstract Slides Video
Presentation thumbnail
Empagliflozin promotes reverse remodeling via cardiometabolic reprogramming in established pressure-overload left ventricular hypertrophy
Doctor M. Ernst (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
ECM-derived exerkines COL1A2-pep1 attenuate cardiac remodeling by enhancing mitophagy through the mtDNA-cGAS-STING pathway
Mr H. Ci (Shanghai, CN) Doctor L. Shen (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac hypertrophy and pressure overload

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
The cardiac sympathetic co-transmitter neuropeptide-Y is pro-arrhythmic in human cardiomyocytes by lengthening activation-recovery interval
31 August 2024
thumbnail
Congress Presentation
Melanocortin 1 receptor deficiency protects against pathological cardiac hypertrophy
25 August 2023
thumbnail
Congress Presentation
Moderate coffee/caffeine intake attenuates cardiac remodelling through fibroblast-selective NCX/NFATc3 signalling
31 August 2026
thumbnail
Congress Presentation
S1P as a novel target to address adverse outcomes following acute myocardial infarction
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources